Albany – NY, Oct. 20, 2015 (GLOBE NEWSWIRE) — A recent study by Transparency Market Research (TMR) forecasts that the global high potency active pharmaceutical ingredients (HPAPIs) market will grow at a CAGR of 9.9% between 2012 and 2018. TMR, a market intelligence company based in the United States, in its recently released report states that the global high potency active pharmaceutical ingredients (HPAPIs) market will report a worth of US$17.5 billion by 2018 from US$9.1 billion in 2011. The report titled ‘High Potency Active Pharmaceutical Ingredients (HPAPIs) Market – Global Industry Analysis, Size, Growth, Share and Forecast 2012 – 2018‘ is available for sale on the website.
Browse Market Research Report on Global High Potency Active Pharmaceutical Ingredients Market:
According to this market research report, the global high potency active pharmaceutical ingredients (HPAPIs) market is a rapidly growing industry in the overall healthcare sector. HPAPIs refer to compounds and substances that help in treating various illnesses and anomalies such as hormonal imbalances, respiratory problems, and also serious diseases such as cancer. Presently, a significant factor driving the global HPAPIs market is the expansion of the global oncology therapeutics industry. Rising demand for oncology products is expected to fuel the global HPAPIs market in the coming years. The current trend in the global HPAPIs market is of patented high potency drug development. Some of the factors driving the global HPAPIs market are most of the blockbuster drugs reaching their patent expiries, greater preference of insurance companies for generic drugs over patented ones, and promotion of generic drugs by the U.S. government in an order to decrease the national medical burden.
The TMR report segments the global HPAPIs market on the basis of type of synthesis, type of manufacturers, type of markets, and geography. Based on type of synthesis, this market is categorized into biotech HPAPI and synthetic HPAPI. On the basis of type of manufacturers, the HPAPIs market is classified into in-house or captive manufacturers and third party or merchant manufacturers. Generic HPAPI and innovative HPAPI are the two types of markets in the global HPAPIs market. Latest industry reports conclude that this market has been witnessing favorable growth trends and is anticipated to grow steadily in the years to come. There are several factors that hamper the growth of the global HPAPIs market. Some of these include regulatory issues, absence of quality standards, and the problem of product differentiation witnessing the manufacturers of active pharmaceutical ingredients (APIs).
Get Sample Report Copy of High Potency Active Pharmaceutical Ingredients (HPAPIs) Market:
Geographically, the research study segments the global HPAPIs market into Asia Pacific, North America, Europe, and Rest of the World. In terms of volume and revenue, the HPAPIs market is led by North America. However, Asia Pacific will hold the highest share in the overall market for HPAPIs, owing to the expanding HPAPIs market in China and India. Favorable performance of the Asia Pacific HPAPIs market can be attributed to factors such as better healthcare systems, economic growth, and greater healthcare awareness. The research report identifies some of the key companies in the global HPAPIs market which include Ranbaxy Laboratories Limited, BASF Se, Royal Dsm Nv, Hospira Inc., Teva Pharmaceutical Industries Limited, Covidien Plc., Boehringer Ingelheim Gmbh, and Matrix Laboratories Limited.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
CONTACT: Mr. Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: email@example.com Website: http://www.transparencymarketresearch.com